Genotype-phenotype correlation for pulmonary function in cystic fibrosis

de Gracia, J.; Mata, F.; Álvarez, A.; Cosals, T.; Gatner, S.; Vendrell, M.; de la Rosa, D.; Guarner, L.; Hermosilla, E.
July 2005
Thorax;Jul2005, Vol. 60 Issue 7, p558
Academic Journal
Background: Since the CFTR gene was cloned, more than 1000 mutations have been identified. To date, a clear relationship has not been established between genotype and the progression of lung damage. A study was undertaken of the relationship between genotype, progression of lung disease, and survival in adult patients with cystic fibrosis (CF). Methods: A prospective cohort of adult patients with CF and two CFTR mutations followed up in an adult cystic fibrosis unit was analysed. Patients were classified according to functional effects of classes of CFTR mutations and were grouped based on the CFTR molecular position on the epithelial cell surface (I-Il/I-Il, I-II/III-V). Spirometric values, progression of lung disease, probability of survival, and clinical characteristics were analysed between groups. Results: Seventy four patients were included in the study. Patients with genotype I-Il/I-Il had significantly lower current spirometric values (p<0.001), greater loss of pulmonary function (p<0.04), a higher proportion of end-stage lung disease (p<0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% Cl 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-Il/Ill, I-ll/IV and I-II/V (p<0.001). Conclusions: The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival.


Related Articles

  • Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Goubau, C.; Wilschanski, M.; Skalická, V.; Lebecque, P.; Southern, K. W.; Sermet, I.; Munck, A.; Derichs, N.; Middleton, P. G.; Hjelte, L.; Padoan, R.; Vasar, M.; De Boeck, K. // Thorax;Aug2009, Vol. 64 Issue 8, p18 

    Background: In patients with symptoms suggestive of cystic fibrosis (CF) and intermediate sweat chloride values (30-60 mmol/l), extensive CFTR gene mutation analysis and nasal potential difference (NPD) measurement are used as additional diagnostic tests and a positive result in either test...

  • PROFILUL MUTAÅ¢IILOR ÃŽN GENA CFTR LA PACIENÅ¢II CU FIBROZÄ‚ CHISTICÄ‚ DIN ROMÂNIA. Frenţescu, Lucian // Clujul Medical;Mar2010, Vol. 83 Issue 1, p163 

    Cystic fibrosis (CF) is the most frequent genetic disease with autosomal-recessive transmission in the Caucasian populations. This disorder is produced by the defects of a chloride ion transporter, named Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). This paper summarizes the...

  • Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Gomez-Lira, Macarena; Bonamini, Deborah; Castellani, Carlo; Unis, Lorenza; Cavallini, Giorgio; Assael, Baroukh Maurice; Pignatti, Pier Franco // European Journal of Human Genetics;Jul2003, Vol. 11 Issue 7, p543 

    Idiopathic chronic and acute recurrent pancreatitis (IP) have been associated with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Mutations in the serine protease inhibitor Kazal 1 (SPINK1) have been described in some idiopathic chronic patients and it has been...

  • Atypical cystic fibrosis--diagnostic and management dilemmas. Wallis, Colin // Journal of the Royal Society of Medicine (Supplement);Jan2003, Vol. 96 Issue 43, p2 

    The article focuses on the diagnosis and management of dilemmas concerning atypical cystic fibrosis (CF). CF usually arises from two disease-forming mutations in the gene for CF transmembrane regulator on chromosome 7. The range of conditions that fall into the atypical category of CF are...

  • Low Frequency of the ΔF508 Mutation of the CFTR Gene in a Highly Admixed Population in Bahia, Brazil. Moura Costa, Fabiana Maia; Santana, Maria Angélica; Moreira Lemos, Antônio Carlos; Galvão-Castro, Bernardo; Acosta, Angelina Xavier // Human Biology;Jun2007, Vol. 79 Issue 3, p293 

    Cystic fibrosis (CF) is the most common autosomal recessive disease in the European (Caucasian) population, with an incidence of 1:2,000 to 1:8,000. The ΔF508 mutation (66%) is predominant among more than 1,300 different mutations of the CFTR gene. The population of the state of Bahia, in...

  • An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion. Stanke, Frauke; Hedtfeld, Silke; Becker, Tim; Tümmler, Burkhard // BMC Medical Genetics;2011, Vol. 12 Issue 1, p62 

    Background: F508del-CFTR, the most frequent disease-causing mutation among Caucasian cystic fibrosis (CF) patients, has been characterised as a mutant defective in protein folding, processing and trafficking. We have investigated the two neighbouring cytokeratin genes KRT8 and KRT18 in a...

  • AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis. Beucher, Julie; Boëlle, Pierre-Yves; Busson, Pierre-François; Muselet-Charlier, Cé line; Clement, Annick; Corvol, Harriet // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    The clinical course of cystic fibrosis (CF) varies between patients bearing identical CFTR mutations, suggesting the involvement of modifier genes. We assessed the association of lung disease severity with the variant AGER -429 T/C, coding for RAGE, a pro-inflammatory protein, in CF patients...

  • Clinical phenotype of cystic fibrosis patients with the G551D mutation. COMER, D. M.; ENNIS, M.; MCDOWELL, C.; BEATTIE, D.; RENDALL, J.; HALL, V.; ELBORN, J. S. // QJM: An International Journal of Medicine;Nov2009, Vol. 102 Issue 11, p793 

    Background: Data on whether the phenotype of cystic fibrosis (CF) patients with compound heterozygocity for G551D (Gly551Asp) differs from patients with F508del (Phe508del) homozygous mutations is divergent.

  • Establishing a diagnosis of cystic fibrosis. Southern, KW; Peckham, D // Chronic Respiratory Disease;2004, Vol. 1 Issue 4, p205 

    Cystic fibrosis (CF) is a recessively inherited condition caused by mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Characterization of the genetic defect has improved understanding of the condition and, in the majority of cases, diagnosis is straightforward....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics